BDNF and metabolic syndrome: Alterations in peripheral BDNF signaling could potentially be a common denominator for the metabolic syndrome spectrum, which ranges from impaired glucose tolerance to overt diabetes, to mild atherogenesis to clinical coronary artery disease.